The progestogen content of combined oral contraceptives and venous thromboembolic risk
Hannaford, P.C.
Bmj 343: D6592
2011
ISSN/ISBN: 1756-1833 PMID: 22028481 DOI: 10.1136/bmj.d6592Document Number: 563498
Document emailed within 0-6 h
Related Documents
Shapiro, S.; Rosenberg, L.; Hoffman, M.; Kelly, J.P.; Cooper, D.D.; Carrara, H.; Denny, L.E.; du Toit, G.; Allan, B.R.; Stander, I.A.; Williamson, A-Lise. 2003: Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa) Cancer Causes and Control: Ccc 14(5): 485-495Shapiro, S.; Rosenberg, L.; Hoffman, M.; Kelly, J.P.; Cooper, D.D.; Carrara, H.; Denny, L.E.; du Toit, G.; Allan, B.R.; Stander, I.A.; Williamson, A-Lise. 2003: Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa) Cancer Causes and Control: Ccc 14(5): 485-495
Sandset, P.Morten. 2014: Combined oral contraceptives increase risk of venous thrombosis according to oestrogen dose and type of progestogen Evidence-Based Medicine 19(5): 194
Spitzer, W.O.; Lewis, M.A.; Heinemann, L.A.; Thorogood, M.; MacRae, K.D. 1996: Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women Bmj 312(7023): 83-88
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Petitti, D.B.; Wingerd, J.; Pellegrin, F.; Ramcharan, S. 1978: Oral contraceptives, smoking, and other factors in relation to risk of venous thromboembolic disease American Journal of Epidemiology 108(6): 480-485
Sugimura, M.; Terao, T. 1999: Oral Contraceptives and Thrombosis. do Third-generation Oral Contraceptives Enhance Venous Thromboembolic Disease? Japanese Journal of Thrombosis and Hemostasis 10(2-3): 128-135
Rosenblatt, K.A.; Thomas, D.B. 1991: Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma. the WHO Collaborative Study of Neoplasia and Steroid Contraceptives International Journal of Cancer 49(6): 870-874
Rosenblatt, K.A.; Thomas, D.B. 1991: Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma. the WHO Collaborative Study of Neoplasia and Steroid Contraceptives International Journal of Cancer 49(6): 870-874
Rosenblatt, K.A.; Thomas, D.B. 1991: Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma. the WHO Collaborative Study of Neoplasia and Steroid Contraceptives International Journal of Cancer 49(6): 870-874
Drill, V.A.; Calhoun, D.W. 1972: Oral contraceptives and thromboembolic disease. II. Estrogen content of oral contraceptives JAMA 219(5): 593-596
Saguil, A. 2015: Risk of venous thromboembolism with use of combined oral contraceptives American Family Physician 91(5): 287-288
World-Health-Organization-Collaborative-Study-Of-Cardiovascular-Disease-And-Steroid-Hormone-Contraception 1998: Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives: Results of an international, multicenter, case-control study Contraception 57(5): 315-324
World-Health-Organization-Collaborative-Study-Of-Cardiovascular-Disease-And-Steroid-Hormone-Contraception 1998: Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives: Results of an international, multicenter, case-control study Contraception 57(5): 315-324
Sheth, A.; Jain, U.; Sharma, S.; Adatia, A.; Patankar, S.; Andolsek, L.; Pretnar-Darovec, A.; Belsey, M.A.; Hall, P.E.; Parker, R.A.; Ayeni, S.; Pinol, A.; Li Hoi Foo, C. 1982: A randomized, double-blind study of two combined and two progestogen-only oral contraceptives Contraception 25(3): 243-252
Plu-Bureau, Gève. 2015: Combined oral contraceptives and risk of venous thromboembolism: there is higher risk in new generations compared to second generations, but paradoxically not in norgestimate-containing-pills Evidence-Based Medicine 20(5): 189
Vinogradova, Y.; Coupland, C.; Hippisley-Cox, J. 2015: Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases Bmj 350: H2135
Nightingale, A.L.; Lawrenson, R.A.; Simpson, E.L.; Williams, T.J.; MacRae, K.D.; Farmer, R.D. 2000: The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 5(4): 265-274